Results 181 to 190 of about 29,710 (291)

Microalgae Oil Attenuates Liver Fat Deposition in NAFLD via Modulation of Anti‐Lipogenic Genes and Insulin Signaling Pathways in HFD Mice

open access: yesFood Science &Nutrition, Volume 14, Issue 6, June 2026.
Dietary microalgae oil might reverse hepatic lipid deposition in a mouse model of fatty liver. This intervention significantly improves the overall fatty liver condition by reducing lipid accumulation and simultaneously restoring insulin sensitivity. ABSTRACT Non‐alcoholic fatty liver disease (NAFLD) is a leading cause of liver‐related mortality and ...
Athba AlQahtani   +8 more
wiley   +1 more source

Green Biosynthesis of Bioactive Streptomyces Metabolites Using Edible Mushrooms: Implications for Glycemic Control and Hepatic Protection in Diabetic Rats

open access: yesFood Science &Nutrition, Volume 14, Issue 6, June 2026.
Mushroom‐mediated Streptomyces metabolites improved fasting blood glucose, reduced hepatic injury markers, restored antioxidant defenses, and showed supportive molecular docking interactions, indicating potential as a functional food or nutraceutical for diabetes‐associated metabolic and liver protection.
Yahye Ahmed Nageye   +2 more
wiley   +1 more source

Enteromorpha prolifera Polysaccharide Alleviates Type 2 Diabetes via the Gut Microbiota–Liver Axis to Modulate Cholesterol Metabolism

open access: yesFood Science &Nutrition, Volume 14, Issue 6, June 2026.
Enteromorpha prolifera polysaccharides may help restore lipid metabolism homeostasis by gently remodeling the gut microbiota to enrich beneficial bacteria and SCFAs, which in turn appears to modulate hepatic functions through the portal vein by downregulating cholesterol synthesis and promoting its metabolism. This coordinated process potentially leads
Liuying Zhu   +5 more
wiley   +1 more source

Structural Characterization and Hypoglycemic Effects of a Purified Polysaccharide From Cinnamomum cassia

open access: yesFood Science &Nutrition, Volume 14, Issue 6, June 2026.
CCP1A, a polysaccharide purified from Cinnamomum cassia with a molecular weight of approximately 8.16 kDa and rich in glucose and galacturonic acid, exerts anti‐type 2 diabetes effects through a multi‐target synergistic mechanism. On one hand, it delays intestinal glucose absorption by inhibiting the activities of α‐amylase and α‐glucosidase in the ...
Liquan Zhou   +6 more
wiley   +1 more source

Participant satisfaction across three trial arms with varying degrees of decentralisation in the RADIAL proof-of-concept trial. [PDF]

open access: yesTrials
Kopanz J   +6 more
europepmc   +1 more source

Portable Home-Use Triglyceride Meter Demonstrates Good Agreement With Plasma Laboratory Measures During Pregnancies Complicated by Metabolic Disease. [PDF]

open access: yesEndocrinol Diabetes Metab
Farabi SS   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy